Breaking News

Unity Biotechnology Inc (UBX)

NASDAQ

Add to/Remove from a Portfolio Add to Watchlist

1.500 +0.020 +1.35%

26/04 - Closed. Currency in USD ( Disclaimer )

After Hours

1.520

+0.020

+1.333%

22:50:29 - Real-time Data

Volume: 38,469
Bid/Ask: 1.480 / 1.520
Day's Range: 1.470 - 1.520

Type: Equity

Market: United States

General
Chart
- Streaming Chart
- Interactive Chart
News & Analysis
- News
Financials
Technical
Forum

NASDAQ:UBX Financials

This summary provides an overview of the most significant critical numbers from each of the Unity Biotechnology Inc financial reports, including theUnity Biotechnology Inc income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the NASDAQ:UBX financials over time via breakdowns of their annual reports.

Unity Biotechnology, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 4.34 million compared to USD 7.42 million a year ago. Basic loss per share from continuing operations was USD 0.28 compared to USD 0.52 a year ago. Diluted loss per share from continuing operations was USD 0.28 compared to USD 0.52 a year ago.

Annual Quarterly

Advanced Financial Summary

TTM = Trailing Twelve Months

MRQ = Most Recent Quarter

UBX Income Statement & Profits

Gross margin TTM -

Operating margin TTM 0%

Net Profit margin TTM 0%

Return on Investment TTM -40.86%

Total Revenue Net Income

Period Ending:	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Total Revenue
Gross Profit	-1.73	-4.9	-6.13	-5.84
Operating Income	-7.68	-9.33	-11.36	-10.65
Net Income	-1.5	-15.29	-12.2	-10.86

UBX Balance Sheet

Quick Ratio MRQ 5.51

Current Ratio MRQ 5.94

LT Debt to Equity MRQ -

Total Debt to Equity MRQ 95.04%

Total Assets Total Liabilities

Period Ending:	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Total Assets		69.27	101.01	114.26
Total Liabilities	37.29	33.06	51.6	55.63
Total Equity	28.4	36.21	49.41	58.63

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM -2.21

Revenue/Share TTM -

Operating Cash Flow 0.00%

Cash Net Change in Cash

Period Ending:	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Period Length:	0 Months	0 Months	0 Months	0 Months
Cash From Operating Activities		-7.11	-11.08	-11.32
Cash From Investing Activities	15.11	14.25	9.85	21.28
Cash From Financing Activities	4.39	-18.38	-2.62	0.274
Net Change in Cash			-3.85	10.24

* In Millions of USD (except for per share items)

Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com UK's comment guidelines and agree to the terms described.

I Agree

UBX Price Commentary

Write your thoughts about Unity Biotechnology Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Taner Kaplankiran Nov 28, 2019 9:15

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

the company raised another $55 million in 2018 (for $210 million in total funding) before going public just a couple of months later in May with a pre-IPO valuation of $712 million. Currently, its market cap sits at about a third of that. Unity targets senescent cells (sometimes referred to as zombie cells), which are cells that have stopped dividing but accumulate in tissues and organs, causing inflammation and other problems as we age. The company is in a phase 2 clinical trial with a drug candidate to treat osteoarthritis of the knee. The study is expected to enroll approximately 180 patients with initiation expected in the fourth quarter of 2019 and initial 12-week results expected in the second half of 2020.

1 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="202765675">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="202765675" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="202765675" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="202765675">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d51-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

FTSE 100	8,139.83	+60.97	+0.75%
DAX	18,166.91	+249.63	+1.39%
Euro Stoxx 50	5,006.65	+67.64	+1.37%
S&P 500	5,099.96	+51.54	+1.02%
Nikkei 225	37,943.50	+315.02	+0.84%
Dow Jones	38,239.66	+153.86	+0.40%
FTSE 100 Futures	8,169.5	+17.6	+0.22%

Brent Oil	89.38	+0.37	+0.42%
Crude Oil WTI	83.66	+0.09	+0.11%
Gold	2,349.60	+7.10	+0.30%
Silver	27.380	-0.122	-0.44%
Copper	4.5800	+0.0485	+1.07%
London Cocoa	9,491.00	-126.00	-1.31%
London Wheat	183.45	+2.90	+1.61%

U.K. 10Y	4.3690	+0.0410	+0.95%
U.K. 5Y	4.2855	+0.0375	+0.88%
U.K. 2Y	4.5180	+0.0360	+0.80%
Germany 10Y	2.5770	+0.0030	+0.12%
U.S. 10Y	4.663	-0.006	-0.13%
U.S. 5Y	4.687	-0.005	-0.11%
U.S. 2Y	4.993	-0.007	-0.13%

Lloyds Banking	52.30	+1.10	+2.15%
Vodafone Group PLC	69.080	+0.080	+0.12%
Barclays	204.35	+0.35	+0.17%
BT Group	105.00	+0.30	+0.29%
HSBC	663.60	+1.70	+0.26%
BHP Group Ltd	2,250.00	-61.00	-2.64%
Exxon Mobil	117.86	-3.47	-2.86%

Recent Quotes

	Name	Price	Chg.	Chg. %
	UBX	1.500	+0.020	+1.35%

Market Movers

Name	Last	Chg. %	Vol.
Barclays	204.35	+0.17%	107.96M
NatWest Group	307.40	+6.07%	56.83M
Darktrace	602.00	+16.44%	39.67M
Anglo American	2,643.0	+3.24%	12.82M
Shell	2,903.5	+0.09%	8.12M
Unilever	4,133.0	+1.25%	4.57M
AstraZeneca	11,988.0	-0.32%	2.34M

Name	Last	Chg. %	Vol.
UIE PLC	222.00	+100000.00%	0.94K
DMK Pharmaceuticals	0.03	+100000.00%	0
Phoenix Mecano AG	477.00	+100000.00%	0.11K
MFE MEDIAFOREUROPE NV B	3.774	+212.16%	9.75K
Guerbet	37.70	+129.60%	0.39K
Frontline	259.00	+128.60%	2.44K
Zscaler	178.3516	+102.79%	0.41K

Name	Last	Chg. %	Vol.
H Lundbeck B	32.96	-81.03%	130.42K
BioGaia B	115.00	-77.69%	0.40K
Hydrogen Refueling	5.00	-66.03%	0.04K
Tomra Systems	139.60	-59.86%	65.31K
Ekinops SA	3.36	-56.72%	0.06K
Atlas Copco B	166.90	-55.83%	15.03M
Electrolux B	95.78	-52.58%	87.04K